Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies-Reference-Cited by-同舟云学术

Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies

Published:2022 Issue:1 Volume:54 Page:80
ISSN:2093-2340
Container-title:Infection & Chemotherapy
language:en
Short-container-title:Infect Chemother

Author:

Ohashi Takashi¹^ORCID,Fujita Yukiyoshi¹^ORCID,Irisawa Hiroyuki²^ORCID,Nakaminami Hidemasa³^ORCID,Arai Takahiro¹^ORCID,Takahashi Masumi¹^ORCID,Momiyama Emi¹^ORCID,Murata Naoya²^ORCID,Murayama Kayoko²^ORCID,Saito Taeko¹^ORCID

Affiliation:

1. Division of Pharmacy, Gunma Prefectural Cancer Center, Gunma, Japan.

2. Department of Hematology, Gunma Prefectural Cancer Center, Gunma, Japan.

3. Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Publisher

Korean Society of Infectious Diseases and Korean Society for Chemotherapy

Subject

Pharmacology (medical),Infectious Diseases

Link

https://icjournal.org/pdf/10.3947/ic.2021.0126

Reference40 articles.

1. The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

2. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

3. Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and Granulocytopenia

4. Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arbekacin;Reactions Weekly;2022-08-06